3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Rectal Neoplasms
11
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Nasopharyngeal Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Neoplasms
2
Adenocarcinoma
2
Pathologic Complete Response
1
Overall Survival Comparison Between the 2 Arms
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Margins of Excision
1
Lymphatic Metastasis
1
Locally Advanced Malignant Neoplasm
1
Laryngeal Neoplasms
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
HPV-Related Squamous Cell Carcinoma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Adenosquamous
1
Breast Neoplasms
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Cyclophosphamide
3
Epirubicin
2
Docetaxel
2
Carboplatin
2
Capecitabine
2
Azacitidine
2
venetoclax
1
tegafur-gimeracil-oteracil
1
taxane
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pirarubicin
1
pertuzumab
1
pembrolizumab
1
olaparib
1
cc-486
1
Trastuzumab
1
Thalidomide
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Nivolumab
1
Monatide (IMS 3015)
1
Methotrexate
1
Magnetic Resonance Imaging
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pathologic Complete Response
×
Chemoradiotherapy
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled